ARKG vs VGK
ARK Genomic Revolution ETF vs Vanguard FTSE Europe ETF
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
VGK$89.42
Vanguard FTSE Europe ETF
European developed-market equities.
Expense: 0.06%Yield: 2.95%
Quick take
- • VGK has the lower expense ratio at 0.06% vs 0.75% for ARKG.
- • VGK pays a higher dividend yield (2.95%).
Side-by-side metrics
| Metric | ARKG | VGK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.06% |
Dividend yield Trailing 12-month yield. | 0.00% | 2.95% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $37.08B |
YTD return | 66.55% | 9.90% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.88 |
P/E ratio | — | 17.79 |
Last price | $47.17 | $89.42 |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
VGK top holdings
Top holdings · VGK
| ASML.AS | ASML Holding NV | 4.47% |
| HSBA.L | HSBC Holdings PLC | 2.19% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.89% |
| SHEL.L | Shell PLC | 1.79% |
| NOVN.SW | Novartis AG Registered Shares | 1.72% |
| AZN.L | AstraZeneca PLC | 1.57% |
| NESN.SW | Nestle SA | 1.51% |
| SIE.DE | Siemens AG | 1.45% |
| SAP.DE | SAP SE | 1.32% |
| SAN.MC | Banco Santander SA | 1.29% |
Sector breakdown · VGK
Real Estate1.4%
Consumer Cyclical6.6%
Basic Materials5.4%
Consumer Defensive7.5%
Technology9.4%
Communication Services2.8%
Financial Services25.4%
Utilities4.4%
Industrials19.5%
Energy5.5%
Healthcare12.1%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VGK
VGK (Vanguard FTSE Europe ETF) is European developed-market equities. Managed by Vanguard, the fund carries $37.1B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.95%. Its largest holding is ASML Holding NV (ASML.AS), which represents 4.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.